BACKGROUND
Biofeedback-based virtual reality (VR-BF) is a novel, nonpharmacologic method for teaching patients how to control their breathing, which in turn increases their heart rate variability (HRV) and reduces pain. Unlike traditional forms of biofeedback (BF), VR-BF is delivered through a gamified virtual reality (VR) environment, increasing the accessibility and pain-relieving benefits of BF. This is the first study to systematically integrate VR-BF in perioperative management in children and adolescents, with the ultimate goal of evaluating the efficacy of VR-BF to reduce pain, anxiety, and opioid consumption in a subsequent clinical trial once the feasibility and acceptability of this technology have been established.
OBJECTIVE
The primary objective was to develop a clinical trial protocol for VR-BF, encompassing the preoperative education and training and the postoperative application of VR-BF in children undergoing surgery. A secondary objective was to evaluate the patient experience with VR-BF based on self-report.
METHODS
A total of 23 patients (12-18 years of age) scheduled for surgery at Nationwide Children's Hospital were recruited using purposive sampling. Following an in-person or virtual training session to learn how to use the equipment and understand the concepts of BF, participants were instructed to independently complete a daily, 10-minute VR-BF session for seven days before surgery and during their inpatient stay. Participants had the option to continue using VR-BF up to two weeks after hospital discharge. Patient and session–level data of VR-BF usage and achievement of target HRV parameters were measured to refine a treatment protocol, including the optimal frequency and duration of sessions before and after surgery for this population. Standardized questionnaires and semi-structured interviews were conducted to obtain additional qualitative information about the patients’ experiences with VR-BF.
RESULTS
Patient-level data indicated that the highest odds of achieving at least 1 session under target HRV parameters were observed after 4 sessions (OR 4 vs. 3 sessions=5.1, 95% CI 1.3-20.6; OR 3 vs. 2 sessions=16.6, 95% CI 1.2-217.0). Session-level data showed that a session duration between 9 to 10 minutes provided patients the greatest odds of achieving at least 1 session under target HRV parameters (OR 9 vs. 8 minutes=1.3, 95% CI 1.1-1.7; OR 8 vs. 7 minutes=1.4, 95% CI 1.1-1.8; OR 10 vs. 9 minutes=1.0, 95% CI 0.9-1.2). Qualitative data revealed patient satisfaction with the VR-BF technology, particularly in managing perioperative stress (n=17, 85%). Few patients reported VR-BF as beneficial for pain (n=8, 40%).
CONCLUSIONS
For children and adolescents to independently learn behavioral strategies shown to provide pain relief with VR-BF, the current study recommends that patients use once-daily 10-minute sessions for 5 days leading up to the surgery date. To integrate VR-BF as a therapeutic intervention, patients will be instructed to complete three 10-minute sessions a day for 7 days after surgery.
CLINICALTRIAL
ClinicalTrials.gov; NCT04943874; https://clinicaltrials.gov/ct2/show/NCT04943874
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.